ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA and Apremilast MRI Study in PsA

188 views
December 14, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology.

Comments 0
Login to view comments. Click here to Login